Tata Communications Transformation Services Receives Frost & Sullivan's 2025 Global Telecom Managed Services Company of the Year Award
The recognition underscores TCTS's innovation-led approach, AI-powered automation, and customer-centric service delivery across global telecom networks.
SAN ANTONIO, June 24, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that Tata Communications Transformation Services (TCTS) has been awarded the 2025 Global Telecom Managed Services Company of the Year Award for its outstanding achievements in innovation, digital transformation, and customer-centric service delivery. This recognition highlights TCTS' consistent leadership in driving measurable outcomes, strengthening its market position, and delivering automation-powered network transformation in a complex and evolving landscape.
Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: visionary innovation and customer impact. TCTS excelled in both, demonstrating its ability to align strategic initiatives with emerging telecom demands while executing them with efficiency, scale, and AI-enabled agility. "TCTS has successfully developed an end-to-end AI-powered automation architecture that transforms network design, integration, and orchestration for telecom customers," said Rahul Agarwal, Associate Director - ICT at Frost & Sullivan. "The company's proprietary Neo Automata™ suite integrates across multi-vendor environments, enabling predictive, and closed loop incident resolution—all through a unified, single-pane experience. These strategic differentiators have helped TCTS lead the charge toward intelligent networking solutions."
Guided by a forward-looking growth strategy rooted in customer co-creation, automation, and workforce empowerment, TCTS continues to lead the transformation of global telecom networks. Its sustained investments in proprietary platform, Neo Automata™ and its cloud-native Multi-Domain Service Orchestrator offering, have enabled the company to deliver seamless, scalable, and intelligent services across diverse technology environments. These innovations directly address the critical need to reduce turnaround time, eliminate service silos, and streamline last-mile deployments.
Innovation remains at the core of TCTS's operating model. Its automation factories—covering network operations, wireless, fiber, design, and enterprise integration—enable comprehensive AI/ML-driven transformation from design to delivery. Through an AI/ML-first approach embedded in every organizational layer, TCTS has significantly improved the quality, accuracy, and speed of customer solutions.
"This recognition from Frost & Sullivan affirms that even in a crowded and fast-evolving market, a telecom-native company — grounded in execution, powered by automation, and focused on outcomes — can lead from the front," said Agnel Navin, CEO, TCTS. "At TCTS, we na9vigate across technologies, vendors, and geographies, but remain firmly anchored to a single, unwavering belief: transformation only matters when it delivers real, measurable results. I'm immensely proud of our teams who live this belief every day — delivering with consistency and integrity. This honour is a tribute to their dedication."
TCTS' unwavering focus on customer experience and delivery excellence further reinforces its leadership in the market. The company's tiered training ecosystem and investments in advanced telecom labs empower employees with next-generation capabilities in 5G, SD-WAN, AI/ML, and network virtualization. As a result, TCTS has consistently maintained high scores on customer experience indices while driving superior operational outcomes for its clients. Its collaborative work style, rigorous project governance, and emphasis on responsiveness have earned client trust across complex transformation engagements.
Frost & Sullivan commends TCTS for setting a benchmark in strategy execution, digital leadership, and customer engagement. The company's automation-first mindset, innovation pipeline, and people-first culture are actively reshaping the future of the telecommunications landscape.
Each year, Frost & Sullivan presents the Company of the Year Award to an enterprise that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The award celebrates visionary organizations that are redefining their industries through excellence in innovation and sustainable growth.
Frost & Sullivan Best Practices awards recognize companies in regional and global markets for demonstrating excellence in leadership, technological innovation, customer service, and strategic product development. Analysts benchmark market participants through in-depth interviews, research, and comparative performance analysis to identify industry-leading best practices.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Contact:
Tarini Singh
E:
About Tata Communications Transformation Services
A 100% subsidiary of Tata Communications, Tata Communications Transformation Services (TCTS) is a leading global provider of network transformation and modernization solutions and services. TCTS enables communication service providers to navigate the multi-domain, multi-technology landscape with a portfolio of offerings that span across: Core connectivity, 5G and mobility, telco cloud and virtualization, network security and unified communications and collaboration. The company's AI-driven network automation approach brings together people, processes and possibilities that have a lasting impact on the network management lifecycle.
For more information, please visit www.tatacommunications-ts.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
4 hours ago
- Cision Canada
Tata Communications Transformation Services Receives Frost & Sullivan's 2025 Global Telecom Managed Services Company of the Year Award
The recognition underscores TCTS's innovation-led approach, AI-powered automation, and customer-centric service delivery across global telecom networks. SAN ANTONIO, June 24, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that Tata Communications Transformation Services (TCTS) has been awarded the 2025 Global Telecom Managed Services Company of the Year Award for its outstanding achievements in innovation, digital transformation, and customer-centric service delivery. This recognition highlights TCTS' consistent leadership in driving measurable outcomes, strengthening its market position, and delivering automation-powered network transformation in a complex and evolving landscape. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: visionary innovation and customer impact. TCTS excelled in both, demonstrating its ability to align strategic initiatives with emerging telecom demands while executing them with efficiency, scale, and AI-enabled agility. "TCTS has successfully developed an end-to-end AI-powered automation architecture that transforms network design, integration, and orchestration for telecom customers," said Rahul Agarwal, Associate Director - ICT at Frost & Sullivan. "The company's proprietary Neo Automata™ suite integrates across multi-vendor environments, enabling predictive, and closed loop incident resolution—all through a unified, single-pane experience. These strategic differentiators have helped TCTS lead the charge toward intelligent networking solutions." Guided by a forward-looking growth strategy rooted in customer co-creation, automation, and workforce empowerment, TCTS continues to lead the transformation of global telecom networks. Its sustained investments in proprietary platform, Neo Automata™ and its cloud-native Multi-Domain Service Orchestrator offering, have enabled the company to deliver seamless, scalable, and intelligent services across diverse technology environments. These innovations directly address the critical need to reduce turnaround time, eliminate service silos, and streamline last-mile deployments. Innovation remains at the core of TCTS's operating model. Its automation factories—covering network operations, wireless, fiber, design, and enterprise integration—enable comprehensive AI/ML-driven transformation from design to delivery. Through an AI/ML-first approach embedded in every organizational layer, TCTS has significantly improved the quality, accuracy, and speed of customer solutions. "This recognition from Frost & Sullivan affirms that even in a crowded and fast-evolving market, a telecom-native company — grounded in execution, powered by automation, and focused on outcomes — can lead from the front," said Agnel Navin, CEO, TCTS. "At TCTS, we na9vigate across technologies, vendors, and geographies, but remain firmly anchored to a single, unwavering belief: transformation only matters when it delivers real, measurable results. I'm immensely proud of our teams who live this belief every day — delivering with consistency and integrity. This honour is a tribute to their dedication." TCTS' unwavering focus on customer experience and delivery excellence further reinforces its leadership in the market. The company's tiered training ecosystem and investments in advanced telecom labs empower employees with next-generation capabilities in 5G, SD-WAN, AI/ML, and network virtualization. As a result, TCTS has consistently maintained high scores on customer experience indices while driving superior operational outcomes for its clients. Its collaborative work style, rigorous project governance, and emphasis on responsiveness have earned client trust across complex transformation engagements. Frost & Sullivan commends TCTS for setting a benchmark in strategy execution, digital leadership, and customer engagement. The company's automation-first mindset, innovation pipeline, and people-first culture are actively reshaping the future of the telecommunications landscape. Each year, Frost & Sullivan presents the Company of the Year Award to an enterprise that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The award celebrates visionary organizations that are redefining their industries through excellence in innovation and sustainable growth. Frost & Sullivan Best Practices awards recognize companies in regional and global markets for demonstrating excellence in leadership, technological innovation, customer service, and strategic product development. Analysts benchmark market participants through in-depth interviews, research, and comparative performance analysis to identify industry-leading best practices. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact: Tarini Singh E: About Tata Communications Transformation Services A 100% subsidiary of Tata Communications, Tata Communications Transformation Services (TCTS) is a leading global provider of network transformation and modernization solutions and services. TCTS enables communication service providers to navigate the multi-domain, multi-technology landscape with a portfolio of offerings that span across: Core connectivity, 5G and mobility, telco cloud and virtualization, network security and unified communications and collaboration. The company's AI-driven network automation approach brings together people, processes and possibilities that have a lasting impact on the network management lifecycle. For more information, please visit
Globe and Mail
4 hours ago
- Globe and Mail
2 Technology ETFs to Invest $500 in Right Now
The U.S. stock market has kept investors on the edge in early 2025. Increasing geopolitical tensions, election-year jitters, and President Donald Trump's tariff policies created a shaky start for the year. But things started changing post-April. Inflation data has eased, and corporate earnings were better than expected. That combination improved investor sentiment for technology stocks. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » What's driving this renewed interest in technology stocks? It is primarily artificial intelligence (AI). As demand for AI-driven innovation and cloud infrastructure grows, so does interest in the companies that power these technologies. However, for everyday investors, picking individual winners among companies with competing technologies and elevated valuations can be risky. Exchange-traded funds (ETFs) help fill this need. Even if you have a limited budget of $500, investing in either of these two diversified tech ETFs can provide an innovative and low-risk way to build a strong long-term portfolio. Global X Artificial Intelligence & Technology ETF With the pace of AI adoption rising rapidly across all walks of life and enterprises increasingly embedding AI-powered tools into core operations, many investors are understandably keen to get exposure to this multi-trillion-dollar market. The Global X Artificial Intelligence & Technology ETF (NASDAQ: AIQ), a passively managed ETF that tracks the Indxx Artificial Intelligence & Big Data Index, offers a less risky yet pure-play exposure to the ever-evolving AI landscape. The Global X fund holds stakes in over 80 companies across the U.S., Europe, and Asia, including established and innovative players in areas like big data, machine learning, and AI. The holdings include top-notch players such as Nvidia, Microsoft, Palantir Technologies, ASML, and Baidu. It is well-diversified across the AI value chain, with exposure to hardware, software, and platform players in both the U.S. and international markets. The ETF is market-cap-weighted, meaning that larger companies have a greater influence on its performance. The fund's expense ratio (the annual percentage of funds that are used to cover the ETF's operational costs) of 0.68% is higher than the average expense ratio of index ETFs. However, this is justified since the ETF tracks a thematically constructed index, is rebalanced semi-annually, and involves multiple international holdings. With $3.45 billion in assets under management (AUM), the ETF is also significantly liquid. Considering its numerous advantages, Global X Artificial Intelligence & Technology ETF may prove to be an excellent way for risk-averse long-term investors to invest $500 in AI. VanEck Semiconductor ETF Going hand in hand with the AI boom is the insatiable demand for underlying AI-optimized hardware infrastructure, particularly in data centers, the automotive sector, and industrial applications. Hence, it is no surprise that semiconductor players have been some of the biggest beneficiaries of the ongoing AI revolution. While semiconductors are a cyclical industry, the upcycle has definitely been extended by several secular tailwinds. However, suppose investors want a more diversified and less risky exposure to this trend without speculating which chipmaker will be the next winner. In that case, the VanEck Semiconductor ETF (NASDAQ: SMH) could prove to be a powerful solution. The VanEck fund is a pure-play semiconductor ETF tracking the performance of the MVIS US Listed Semiconductor 25 Index, a modified market-cap-weighted index focusing on 25 of the largest and most liquid U.S.-listed semiconductor companies. Although the index's performance is influenced mainly by the larger players, it also uses capping rules to limit overexposure to any single company. Currently, companies such as Nvidia, Taiwan Semiconductor Manufacturing, ASML, Broadcom, and Advanced Micro Devices account for nearly half of the VanEck fund's total asset holdings. Subsequently, investors are gaining exposure to robust secular trends, including AI, 5G, autonomous vehicles, and edge computing. Additionally, the ETF provides exposure to prominent U.S.-listed international semiconductor companies. SMH has around $25.2 billion in AUM and is highly liquid. It charges a very modest expense ratio of 0.35% and is a cost-effective investment vehicle. Hence, it is evident that the VanEck fund offers an innovative and diversified way to benefit from the upside in the semiconductor industry while controlling for company-specific risks. For investors with $500 or more and a long-term mindset, the VanEck Semiconductor ETF deserves a close look. Should you invest $1,000 in Global X Funds - Global X Artificial Intelligence & Technology ETF right now? Before you buy stock in Global X Funds - Global X Artificial Intelligence & Technology ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Global X Funds - Global X Artificial Intelligence & Technology ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Manali Pradhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Advanced Micro Devices, Baidu, Microsoft, Nvidia, Palantir Technologies, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends Broadcom and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Globe and Mail
14 hours ago
- Globe and Mail
Acromegaly Treatment Market to Reach USD 2.51 Billion by 2030 driven by Expanded Oral Therapies and Rising Diagnosis Rates
"Acromegaly Treatment Market" Mordor Intelligence has published a new report on the acromegaly treatment market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction According to a 2025 report on Acromegaly Treatment Market by Mordor Intelligence the market is projected to grow from USD 1.75 billion in 2025 to USD 2.51 billion by 2030, at a compound annual growth rate (CAGR) of 7.4%. Acromegaly is a rare hormonal disorder caused by excessive secretion of growth hormone (GH), typically due to a benign tumor on the pituitary gland. The condition leads to abnormal growth of bones and tissues, often resulting in physical deformities, metabolic complications, and cardiovascular issues if left untreated. The acromegaly treatment market has been growing steadily as awareness increases, diagnostic capabilities improve, and newer therapeutic approaches emerge. Key Trends The acromegaly treatment market is witnessing several notable trends shaping its trajectory: • Shift toward long-acting and oral formulations Manufacturers are introducing extended-release depot injections and novel oral therapies. The FDA's 2020 approval of MYCAPSSA (oral octreotide) has opened doors for at home administration. Growth hormone receptor antagonists like pegvisomant and emerging oral agents (e.g. paltusotine) are attracting attention due to simplified regimens and improved patient adherence. • Improved diagnosis and earlier detection protocols Updated guidelines and enhanced disease awareness globally are enabling earlier identification of GH secreting pituitary adenomas. This leads to timely treatment and is expected to boost market growth by approximately 1.9% CAGR in North America and Europe. • Geographic growth acceleration in Asia-Pacific Asia-Pacific is projected to grow at an 8.2% CAGR through 2030, outpacing regional averages. Increased healthcare investments, growing specialist density, and expanding private insurance coverage especially in China, Japan, and South Korea are key growth drivers. Market Segmentation The acromegaly treatment market is segmented by product type and distribution channel: By Product Type Somatostatin analogs: Represent the largest segment in 2024 with a 55% market share. These are widely endorsed as first line therapy due to their strong efficacy. Depot formulations (e.g., lanreotide, octreotide) are well established, and clinical use continues to expand. Growth hormone receptor antagonists (GHRAs): Although their market share is smaller currently, this segment is growing faster, projected at roughly 9.5% CAGR to 2030. Products like pegvisomant and oral agents such as paltusotine show strong biochemical control in trials. Dopamine agonists: Utilize a different mechanism and typically serve as adjunct therapy or in mild acromegaly cases. This segment remains niche. Other product types: Includes emerging therapies such as antisense RNA, GHRH receptor blockers, and novel injectables. These are mostly in early pipeline stages and target refractory cases. By Distribution Channel Hospital pharmacies: Captured approximately 61% of the market in 2024, largely due to the need for specialist oversight during initiation, dose titration, and imaging follow up of injectable therapies. Retail pharmacies: Although smaller, this traditional outpatient channel remains important especially for refill prescriptions after stabilization under clinical supervision. Online pharmacies: The fastest growing segment with an estimated CAGR of 13.6% through 2030. Growth is driven by the rise of oral treatments (e.g., MYCAPSSA) and broader telemedicine and digital dispensing adoption. By Geography North America: Largest regional market with 43% share in 2024. Dominance is supported by high diagnosis rates, new treatment approvals, and payer support (e.g., Medicare Part D cap) Europe: A significant market with stable growth, supported by predictable EMA approval processes and health technology assessments. Asia‑Pacific: Fastest growing region at around 8.2% CAGR. Growth is fueled by rising specialist availability and public/private insurance expansions in countries like China, India, Japan, and South Korea. Middle East & Africa: Emerging market with limited current data but increasing interest in rare disease treatment access. South America: Gradual development, with pockets of access in Brazil and Argentina driven by improved regulatory frameworks. Key Players The global acromegaly treatment market shows a moderately concentrated competitive landscape, led by both big pharmaceutical companies and innovative biotechs. Novartis A leading global pharmaceutical company, Novartis stands out in this market thanks to its established portfolio of somatostatin analogs. The report highlights Novartis among the top five companies, reflecting its significant influence and market share in acromegaly treatment. Ipsen Another major specialist in endocrine disorders, Ipsen's Somatuline (lanreotide) program is a consistently high revenue performer. The firm is frequently recognized alongside Novartis and Pfizer as a top acromegaly treatment provider. Pfizer Pfizer is repeatedly listed among the top tier players in acromegaly treatment, indicating its meaningful presence likely via advanced depot therapies and a global distribution network. Recordati S.p.A. Positioned within the core competitive ensemble, Recordati is noted for its focus on rare endocrine diseases and strategic acquisitions in the field, reinforcing its role in the acromegaly treatment space. Amryt Pharma plc Identified as one of the major players, Amryt contributes to the market through innovative therapies and participation in developing newer treatment modalities for acromegaly Conclusion The acromegaly treatment market is on a healthy upward path, largely fueled by therapeutic innovations and improved diagnosis. Transition to long-acting depots and oral therapies offers convenience and enhanced adherence, while robust pipelines in GH receptor antagonists signal sustained growth. Geographically, North America with a 43% market share in 2024 continues to dominate, underpinned by policy measures like the U.S. Medicare Part D cap and proactive health technology assessments. Meanwhile, Asia Pacific is emerging as the fastest growing region, presenting new market opportunities. Looking forward, early diagnosis, increasing access through digital pharmacies, and expanding oral treatment options suggest continued market expansion. With a projected valuation of USD 2.51 billion by 2030 and a steady 7.4% CAGR, the acromegaly treatment landscape will continue to evolve rooted in patient centric delivery modes and clinical advancements. For More Insights: Industry Related Reports: Somatostatin Analogs Market: The Somatostatin Analogs Market Report is segmented by Type (Octreotide, Lanreotide, Pasireotide, and Other Types), by Application (Acromegaly, Neuroendocrine Tumors (NETs), and Other Applications), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and forecasts are provided in terms of value (USD) for all the above segments. Neuroendocrine Tumor Treatment Market : The Neuroendocrine Tumor Treatment Market Report is segmented by Products (Somatostatin Analogs (SSAs), Targeted Therapy, Chemotherapy, and Others), by Indication (Lungs, Pancreas, Gastrointestinal, and Others), by End User (Hospitals, Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report provides five years of historical data along with five years' market forecasts. Get More Insights: Norway Pharmaceutical Market: The Norway Pharmaceutical Market Report is segmented by ATC/Therapeutic Class (Cardiovascular System, Dermatologicals, Genito Urinary System, Anti-infective for Systemic Use, Antineoplastic and Immunomodulating Agents, Musculoskeletal System, Nervous System, Respiratory System, and Others), by Drug Type (Branded and Generic), and by Prescription Type (Prescription Drugs (Rx) and Over the Counter (OTC) Drugs). About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact: media@
